Home > Formulary : Paediatric > Recent Decisions > 2019 >
Decisions 3rd December 2019
Recent JFG Decisions
At the meeting on the 3rd December 2019 the following actions / changes to the formulary were agreed:
Zanamivir (intravenous) (TLS Red)
- for treatment of severe/ complicated influenza A or B virus infection where there is suspected resistance to anti-viral treatments other than zanamivir and who are unable to take oral or inhaled medication
Budesonide orodispersible tablets (Jorveza®) (Amber 3 months)
- Change from TLS Red to TLS Amber 3 months